Abstract
Two patients with Parkinson's disease received treatment with ropinirole and/or pramipexole, during which both experienced sleep attacks. These attacks may be a class effect of non-ergot dopamine agonists. Health care professionals should be aware of the potential of these agents to cause sleep attacks and caution patients about this potentially life-threatening adverse effect.
| Original language | English |
|---|---|
| Pages (from-to) | 724-726 |
| Number of pages | 3 |
| Journal | Pharmacotherapy |
| Volume | 20 |
| Issue number | 6 I |
| DOIs | |
| State | Published - 2000 |
ASJC Scopus subject areas
- Pharmacology (medical)